Balchem

BCPC · NASDAQ

$171.62+$1.20 (+0.70%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $170.42

About BCPC

Balchem Corp. markets specialty performance ingredients and products. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.

Employees: 1,368
Headquarters: Montvale, Maryland
Listed: Jun 3, 1986
Sector: Materials
Industry: Chemicals
Website: balchem.com

Leadership

Balchem executives
Name	Title	Since	Age
Theodore Harris	—	2015	60
C. Martin Bengtsson	—	—	47
Hatsuki Miyata	—	—	48
Frederic Boned	—	—	46
Martin Reid	—	—	57
William Backus	—	—	58
Matthew Wineinger	—	—	58
David Fischer	—	—	62
Kathleen Fish	—	—	67
Daniel Knutson	—	—	68
Olivier Rigaud	—	—	60
Monica Vicente	—	—	59

Revenue by product and region

Fiscal year ended Dec 31, 2025: $1.04B total revenue

By product

Product Sales Revenue$1.04B99.8%
Royalty Revenue$1.89M0.2%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Balchem suppliers and customers
Company	Relationship	Country	Correlation
Eastman Chemical EMN	Supplier and customer	US	0.32

Similar companies

Companies in the same industry as Balchem

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.